The Plan and The Chasm, Why India’s Fight Against Superbugs Hinges on Federal Fixes
Antimicrobial Resistance (AMR) is the quintessential “One Health” crisis of the 21st century. It is a silent, borderless pandemic where the misuse of antibiotics in humans, animals, and agriculture leads to the evolution of “superbugs”—pathogens impervious to our most vital medicines. For India, a nation with a high burden of infectious diseases, dense populations, expansive agricultural and livestock sectors, and often fragmented regulation, AMR is not a future threat; it is a present and accelerating catastrophe. In this context, the release of India’s second National Action Plan on Antimicrobial Resistance (NAP-AMR 2.0) for 2025-29 is a critical, timely intervention. As articulated by experts like Dr. Abdul Ghafur, the new plan is scientifically robust, ambitious in scope, and mature in its recognition of the interconnectedness of human, animal, and environmental health. However, a glaring and potentially fatal flaw threatens to render even this improved plan an exercise in futility: the absence of a binding, accountable, and incentivized mechanism to ensure implementation across India’s powerful and independent states. The battle against AMR is being fought on a fractured battlefield, and no amount of sophisticated strategy from New Delhi can win if the soldiers in the states are not equipped, coordinated, and commanded effectively.
The Evolution: From NAP 1.0 to NAP 2.0 – A Framework Matures
India’s first NAP-AMR (2017-21) was a landmark in acknowledging the crisis. It successfully elevated AMR to a national policy priority, established a multi-sectoral “One Health” framework, and initiated crucial groundwork like strengthening laboratory surveillance networks (the Indian Council of Medical Research’s AMR network) and promoting antibiotic stewardship programs in select hospitals. It laid the conceptual foundation, recognizing that the drivers of resistance span human clinics, veterinary practices, aquaculture ponds, agricultural fields, and pharmaceutical effluent channels.
NAP-AMR 2.0 builds on this foundation with greater sophistication and implementation intent. Its key advancements include:
-
Enhanced One Health Integration: The plan moves beyond acknowledging linkages to proposing more integrated surveillance across human, animal, food, and environmental sectors. It gives sharper focus to contamination pathways in food systems and waste management, where resistant genes and bacteria proliferate.
-
Private Sector Engagement: It explicitly recognizes that a vast majority of human healthcare and veterinary services in India are delivered by the private sector. Any plan that ignores this reality is doomed. NAP 2.0 seeks to bring private hospitals, clinics, pharmacies, and the animal husbandry industry into the fold of stewardship and surveillance.
-
Focus on Innovation: The plan rightly emphasizes the need for rapid diagnostics, point-of-care tools, and research into alternatives to antibiotics (like bacteriophages, vaccines). This is crucial to reduce empiric antibiotic prescribing, a major driver of misuse.
-
Clearer Governance Structure: It proposes stronger national oversight through a Coordination and Monitoring Committee under NITI Aayog and mandates that all States and Union Territories establish State AMR Cells and develop their own State Action Plans (SAPs), aligned with the national framework.
On paper, NAP-AMR 2.0 is a comprehensive, world-class strategic document. Yet, as Dr. Ghafur notes, this is precisely where the problem lies—its potential is trapped on paper.
The Pivotal Gap: The Federal Disconnect in a “One Health” Crisis
The fatal weakness of NAP-AMR 2.0, inherited from its predecessor, is its lack of enforceable mechanisms to ensure state-level adoption and execution. This is not a minor oversight; it strikes at the very heart of India’s constitutional and administrative reality. The principal determinants of AMR—the operational levers of change—are almost entirely under State Jurisdiction:
-
Health: Regulation of hospitals (public and private), medical education, pharmacy acts, and implementation of health programs.
-
Animal Husbandry & Veterinary Services: Oversight of antibiotic use in livestock, poultry, and aquaculture.
-
Agriculture: Management of antibiotic use as pesticides or growth promoters in crops (a less-discussed but emerging issue).
-
Food Safety: Monitoring of antibiotic residues in meat, milk, and other food products.
-
Environment & Waste: Regulation of sewage treatment, pharmaceutical industrial discharge, and manure management.
The national government can issue guidelines, but it cannot command a state drug inspector to enforce prescription-only sale of antibiotics, direct a municipal corporation to treat hospital wastewater, or compel a state agriculture department to educate farmers on prudent antibiotic use. As the experience of NAP 1.0 shows, despite national urging, only a handful of states—Kerala, Madhya Pradesh, Delhi, Andhra Pradesh, Gujarat, Sikkim, Punjab—developed formal State Action Plans. Even fewer translated these plans into coordinated, multi-departmental action on the ground.
The new plan “stresses that States must” act but “does not create any mechanism to ensure that they do so.” There is:
-
No Formal Centre-State Platform: No equivalent of the National Health Mission’s (NHM) regular joint reviews with state health ministers and secretaries.
-
No Statutory Backing: States are not legally required to notify or implement SAPs.
-
No Financial Architecture: The plan lacks dedicated, conditional funding channels (like NHM-linked grants) to incentivize and enable state-level activities. In India’s competitive fiscal federalism, where states have myriad priorities, funding is the most potent signal of importance.
-
No Political Accountability Mechanism: There is no system to bring Chief Ministers, Chief Secretaries, and heads of multiple state departments (Health, Animal Husbandry, Agriculture, Environment) into a single, high-stakes accountability forum for AMR.
Without these elements, NAP-AMR 2.0 risks being a “technical document” admired in Delhi but ignored in state capitals, where the real battle against AMR must be fought.
The Blueprint for a Federal Fix: Learning from Success Stories
India does not need to invent a new model for Centre-State coordination. It has successful templates within its own public health ecosystem. The National Tuberculosis Elimination Programme (NTEP) and the National Health Mission (NHM) offer proven blueprints.
-
Structured Joint Reviews: Both NTEP and NHM operate through regular, high-level joint monitoring missions and review meetings involving central and state officials. These are not optional seminars; they are accountability forums where data is scrutinized, bottlenecks are addressed, and political and bureaucratic attention is focused.
-
Dedicated, Conditional Funding: NHM provides a clear financial pathway. Funds are tied to achieving specific benchmarks and submitting program implementation plans. This “carrot and stick” approach ensures states align their priorities with national goals. AMR control needs a similar “AMR Strengthening Package” under NHM or a separate window.
-
Clear Role Definition: Successful programs clearly delineate the responsibilities of the central ministry (guidance, funding, procurement of certain commodities), the state government (implementation, monitoring), and district-level officers (execution).
-
Political & Administrative Signaling: A formal directive from the Prime Minister’s Office or the Union Health Ministry to all Chief Secretaries, mandating the creation of SAPs and State AMR Cells with a deadline, can create immediate administrative momentum. High-level communication signals that this is a priority.
For AMR, this would translate into creating a National/State AMR Council, chaired by a senior Union Minister (Health) with the active participation of state Health Ministers and the heads of other relevant central ministries (Animal Husbandry, Agriculture, Environment, Chemicals). This council would meet bi-annually to review a national AMR dashboard, address cross-sectoral bottlenecks, and share best practices.
Beyond Health: The Multi-Sectoral Mobilization Imperative
A federal fix must also crack the code of intra-state, inter-departmental coordination. A State AMR Cell housed only in the Health Department is insufficient. It must be a truly cross-cutting authority with the mandate and budget to convene and direct the work of the Animal Husbandry, Agriculture, Food Safety, and Pollution Control Boards. This is an immense bureaucratic challenge, requiring strong political backing from the Chief Minister’s office to break down departmental silos. Kerala’s success in developing a SAP was underpinned by such high-level political will.
Furthermore, engaging the private sector—a major source of antibiotic consumption—requires innovative regulation and partnership. Strengthening the enforcement of Schedule H1 (which mandates prescription for critical antibiotics) and integrating private diagnostic labs into the national AMR surveillance network are essential steps that need active state-level regulatory action.
Conclusion: From Document to Doctrine, From Guideline to Governance
The NAP-AMR 2.0 provides an excellent strategic “what.” What is now desperately needed is the operational “how”—the governance architecture to make it a living reality across India’s diverse and vast landscape. The science of AMR is complex, but the solution to India’s implementation gap is understood: it lies in the politics and mechanics of federal governance.
The time for gentle persuasion is over. The superbugs are evolving faster than our bureaucracy. If India is to avert a post-antibiotic era where routine infections become deadly and modern medicine regresses, it must treat AMR with the same coordinated, war-footing urgency it applied to polio eradication or the COVID-19 response. This means moving from a culture of “plan-making” to one of “program-managing.”
The success of NAP-AMR 2.0 will not be measured by the quality of its document, but by a reduction in antibiotic misuse in a village pharmacy in Uttar Pradesh, by improved infection control in a private hospital in Tamil Nadu, by regulated antibiotic use in a poultry farm in Haryana, and by treated wastewater leaving a pharmaceutical cluster in Hyderabad. These outcomes will only materialize when every state government owns the AMR agenda as its own. Building that ownership requires a binding compact of shared accountability, supported by funds, facilitated by forums, and driven by data. The plan is ready. The system to execute it is not. Until that gap is bridged, India’s fight against the silent pandemic will remain a whisper against a gathering storm.
Questions & Answers
Q1: What are the key advancements in India’s NAP-AMR 2.0 compared to the first plan?
A1: NAP-AMR 2.0 advances on the first plan by: (1) Deeper One Health integration with more focus on food systems and environmental contamination pathways; (2) Explicit engagement of the private sector in human and animal health; (3) Emphasis on innovation for diagnostics and antibiotic alternatives; (4) Clearer governance, mandating State AMR Cells and State Action Plans (SAPs); and (5) Stronger national oversight via a NITI Aayog committee. It is a more implementation-oriented framework.
Q2: Why is the lack of a Centre-State coordination mechanism described as the “pivotal gap” in the plan?
A2: Because the primary drivers of AMR—regulation of hospitals, pharmacies, veterinary practices, agriculture, food safety, and waste management—are under State jurisdiction. Without a formal, binding mechanism (like joint reviews, conditional funding, or statutory mandates), the national plan remains mere guidance with no power to ensure 28 states and 8 UTs actually adopt and implement it. Experience from NAP 1.0 shows most states did not develop or execute SAPs due to this accountability gap.
Q3: How do existing national health programs like the National Health Mission (NHM) provide a model for AMR action?
A3: The NHM provides a proven federal model based on: Structured Joint Reviews (regular Centre-State meetings for accountability); Dedicated Conditional Funding (grants tied to performance and implementation plans, signaling priority); and Clear Role Delineation between central and state authorities. This architecture creates a mutually accountable system that turns national priorities into on-ground action, which is precisely what the NAP-AMR currently lacks.
Q4: What specific structure is proposed to fix the federal implementation gap for AMR?
A4: The article proposes creating a National/State AMR Council, chaired by the Union Health Minister with state Health Ministers and other relevant central ministries (Animal Husbandry, Agriculture, Environment). This high-level political forum would enable regular review, joint decision-making, and problem-solving. Coupled with formal directives to Chief Secretaries to create SAPs and dedicated funding channels (like NHM-linked grants), this would create the necessary political, administrative, and financial impetus for state-level action.
Q5: Beyond Centre-State issues, what is the major intra-state challenge in implementing a “One Health” approach to AMR?
A5: The major intra-state challenge is breaking down bureaucratic silos. AMR requires coordinated action across multiple state departments: Health, Animal Husbandry, Agriculture, Food Safety, and Environment. A State AMR Cell stuck only within the Health Department is ineffective. Success requires a cross-cutting authority with a mandate and budget from the highest state political level (e.g., the Chief Minister’s Office) to convene and direct all these departments—a significant governance hurdle that few states have overcome.
